AOD-9604
AOD-9604 is an hGH 177-191 fragment studied for lipid metabolism, fat oxidation, and cartilage models.
What AOD-9604 is
AOD-9604 is a synthetic analog of the C-terminal lipolytic region of human growth hormone, commonly described as hGH fragment 177-191 with an added tyrosine in some analytical contexts. Research has examined lipid metabolism, beta-adrenergic pathway interactions, fat oxidation, and body-weight effects in animal models. It has also appeared in analytical anti-doping and identification literature.
Despite the name, AOD-9604 is not growth hormone and does not share the full endocrine profile of intact hGH. Human development history exists, but much of the accessible mechanistic literature is preclinical. Research-grade AOD-9604 is Research Use Only and not for human consumption.
Nearly all of the published work on AOD-9604 is preclinical: animal models and cell studies. Human evidence is thinner than the volume of online discussion suggests.
How it works
AOD-9604 is studied as a peptide fragment linked to hGH's lipolytic domain, with preclinical work examining lipolysis, fat oxidation, energy expenditure, and beta-adrenergic pathway relationships. Animal data suggest effects are not simply mediated through the full growth hormone receptor profile. Some studies report changes in beta3-adrenergic receptor expression or lipid-handling markers, while analytical papers focus on detection and metabolism.
Where this compound shows up in research
AOD-9604 is studied by metabolic researchers, endocrinology pharmacologists, anti-doping laboratories, and musculoskeletal model researchers. Reviewers usually separate preclinical mechanism papers from clinical-development claims and gray-market use.
What the research examines
Research areas, not results. A topic on this list is being studied, not settled.
How it appears in the literature
Reported research amounts. These describe what was studied, not what anyone should do.
| Research context | Reported amount | Frequency | Route |
|---|---|---|---|
| Rabbit osteoarthritis model with intra-articular AOD9604 | 250 mcg | weekly in animal study protocol | intra-articular |
| Obese rodent metabolic studies using AOD9604 | 250 mcg – 500 mcg | daily in animal protocols | intraperitoneal or oral in preclinical studies |
Handling & storage
Lyophilized AOD-9604 is commonly stored cold, dry, and protected from light; reconstituted research solutions are generally refrigerated and used promptly.
Notes on combined research
AOD-9604 is often discussed beside metabolic peptides, GLP-1 compounds, or GH secretagogues, but mechanisms and evidence levels differ sharply. Research designs should avoid stacking endocrine and incretin variables unless the study is built to separate appetite, lipolysis, glucose, and body-composition endpoints.
AOD-9604 questions
Published AOD-9604 ranges are largely preclinical or trial-context specific. They should be presented as study exposure values, not dosing advice.
Research examples often use 1-2 mL for small vials. Reconstitution volume only determines concentration for calculations.
Daily values found online often mix animal studies, old development programs, and marketing claims. Literature-based content should identify the source context.
A chart should separate animal mg or mcg exposures, route, species, and vial concentration math. It should not imply a human protocol.
Animal metabolic studies often evaluate outcomes over days to weeks. Analytical detection work uses much shorter in vitro windows.
A practical human half-life is not firmly established in widely used literature. Detection and metabolism studies are more reliable references.
It can be studied with other metabolic variables, but stacking can hide whether results come from appetite, lipolysis, endocrine, or activity changes.
Read the research yourself
These references were validated against the NCBI database. No citation appears here unless it resolves to a real paper.
- Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone.PubMed
- The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice.PubMed
- Detection and in vitro metabolism of AOD9604.PubMed